Synthaverse S.A. (SVE.WA) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computed from published company financials, balance sheet as of 2025-12-31. SVE.WA files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 51.65% | 30.00% | Fail |
| Interest-bearing investments | 1.02% | 30.00% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 29.41% | 33.00% | Pass |
| Interest-bearing investments | 0.55% | 33.00% | Pass |
| Non-liquid assets | 92.46% | at least 20.00% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 27.83% | 33.33% | Pass |
| Cash + interest-bearing securities | 0.55% | 33.33% | Pass |
| Accounts receivable | 7.54% | 33.33% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 27.83% | 33.33% | Pass |
| Cash + interest-bearing securities | 0.55% | 33.33% | Pass |
| Accounts receivable | 7.54% | 50.00% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 38.19% | 33.00% | Fail |
| Cash + interest-bearing securities | 0.75% | 33.00% | Pass |
| Accounts receivable | 9.59% | 33.00% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 36.79% | 33.00% | Fail |
| Cash + interest-bearing securities | 0.73% | 49.00% | Pass |
| Accounts receivable | 9.24% | 49.00% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 36.79% | 33.33% | Fail |
| Cash + interest-bearing securities | 0.73% | 33.33% | Pass |
| Accounts receivable | 9.97% | 49.00% | Pass |
| Non-permissible income | 0.03% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 43.80 | NEUTRAL |
| Stochastic %K (14) | 0.00 | BUY |
| CCI (20) | -61.93 | NEUTRAL |
| Williams %R (14) | -100.00 | BUY |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | -3.97 | SELL |
| Momentum (10) | -0.12 | SELL |
| EMA (10) | 2.97 | SELL |
| SMA (10) | 2.98 | SELL |
| EMA (20) | 2.96 | SELL |
| SMA (20) | 2.97 | SELL |
| EMA (30) | 2.95 | SELL |
| SMA (30) | 2.97 | SELL |
| EMA (50) | 2.94 | SELL |
| SMA (50) | 2.89 | BUY |
| EMA (100) | 3.03 | SELL |
| SMA (100) | 2.93 | SELL |
| EMA (200) | 3.38 | SELL |
| SMA (200) | 3.36 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Biotechnology
Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas in Poland, the rest of the European Union, and internationally. The company operates through the BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anti-D 50 and GAMMA anti-D 150, which are human anti-rh0(d) immunoglobulin products used in the prevention of maternal-fetal conflict in terms of the D antigen with the Rh system; GAMMA anty HBs 200 medications for use in passive prophylaxis hepatitis B virus; and BCG 10 tuberculosis vaccines. It also provides Distreptaza, a medication for chronic ovarian inflammation and hemorrhoidal disease; LAKCID, which is a lactobacillus probiotic drug; and pseudocholinoesteraza, which is a laboratory reagent. In addition, the company engages in the contract production of injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, and suppository forms of drugs. The company was formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. and changed its name to Synthaverse S.A. in July 2023. Synthaverse S.A. was founded in 1944 and is headquartered in Lublin, Poland.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.